Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    AptarGroup, Inc. (ATR)

    Price:

    142.07 USD

    ( - -2.06 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ATR
    Name
    AptarGroup, Inc.
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    Price
    142.075
    Market Cap
    9.323B
    Enterprise value
    9.146B
    Currency
    USD
    Ceo
    Stephan Tanda
    Full Time Employees
    13000
    Website
    Ipo Date
    1993-04-23
    City
    Crystal Lake
    Address
    265 Exchange Drive

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Bausch + Lomb Corporation

    VALUE SCORE:

    8

    Symbol
    BLCO
    Market Cap
    6.534B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    2nd position

    Haemonetics Corporation

    VALUE SCORE:

    9

    Symbol
    HAE
    Market Cap
    2.887B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare

    The best

    ResMed Inc.

    VALUE SCORE:

    11

    Symbol
    RMD
    Market Cap
    36.729B
    Industry
    Medical - Instruments & Supplies
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    23.520
    P/S
    2.468
    P/B
    3.461
    Debt/Equity
    0.574
    EV/FCF
    35.359
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    2.767
    Earnings yield
    0.043
    Debt/assets
    0.291
    FUNDAMENTALS
    Net debt/ebidta
    1.357
    Interest coverage
    9.687
    Research And Developement To Revenue
    0.161
    Intangile to total assets
    0.254
    Capex to operating cash flow
    0.481
    Capex to revenue
    0.073
    Capex to depreciation
    0.955
    Return on tangible assets
    0.100
    Debt to market cap
    0.164
    Piotroski Score
    6.000
    FUNDAMENTALS
    PEG
    -3.910
    P/CF
    16.119
    P/FCF
    31.381
    RoA %
    7.475
    RoIC %
    9.212
    Gross Profit Margin %
    29.582
    Quick Ratio
    1.162
    Current Ratio
    1.623
    Net Profit Margin %
    10.395
    Net-Net
    -19.371
    FUNDAMENTALS PER SHARE
    FCF per share
    4.547
    Revenue per share
    58.110
    Net income per share
    6.041
    Operating cash flow per share
    8.769
    Free cash flow per share
    4.547
    Cash per share
    6.300
    Book value per share
    41.726
    Tangible book value per share
    21.215
    Shareholders equity per share
    41.047
    Interest debt per share
    24.363
    TECHNICAL
    52 weeks high
    164.280
    52 weeks low
    103.230
    Current trading session High
    143.510
    Current trading session Low
    140.430
    DIVIDEND
    Dividend yield
    1.31%
    Payout ratio
    30.8%
    Years of div. Increase
    33.000
    Years of div.
    34.000
    Q-shift
    2.000
    Dividend per share
    1.860
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -11.650
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    22.970
    logo

    Country
    ES
    Sector
    Healthcare
    Industry
    Drug Manufacturers - General
    Dividend yield
    0.015699008%
    Payout Ratio
    27.726907%
    P/E
    14.051
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    26.127
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Distribution
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    25.631
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -16.630
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Plans
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    15.960
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    156.598
    logo

    Country
    IT
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.0039494163%
    Payout Ratio
    0%
    P/E
    25.845
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Instruments & Supplies
    Dividend yield
    0.012129861%
    Payout Ratio
    -18.591866000000003%
    P/E
    -15.123
    DESCRIPTION

    AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

    NEWS
    https://images.financialmodelingprep.com/news/aptargroup-inc-atr-presents-at-bank-of-america-2026-20260225.jpg
    AptarGroup, Inc. (ATR) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript

    seekingalpha.com

    2026-02-25 13:27:54

    AptarGroup, Inc. (ATR) Presents at Bank of America 2026 Global Agriculture and Materials Conference Transcript

    https://images.financialmodelingprep.com/news/insider-selling-aptargroup-nyseatr-insider-sells-49472500-in-stock-20260222.png
    Insider Selling: AptarGroup (NYSE:ATR) Insider Sells $494,725.00 in Stock

    defenseworld.net

    2026-02-22 04:32:54

    AptarGroup, Inc. (NYSE: ATR - Get Free Report) insider Gael Touya sold 3,500 shares of the stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $141.35, for a total value of $494,725.00. Following the completion of the transaction, the insider owned 27,963 shares in the company,

    https://images.financialmodelingprep.com/news/aptar-to-participate-in-upcoming-investor-conferences-20260218.jpg
    Aptar to Participate in Upcoming Investor Conferences

    businesswire.com

    2026-02-18 17:00:00

    CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Participate in Upcoming Investor Conferences.

    https://images.financialmodelingprep.com/news/equinix-inc-eqix-q4-2025-earnings-call-highlights-strong-20260212.png
    Equinix Inc (EQIX) Q4 2025 Earnings Call Highlights: Strong AI-Driven Growth and Record Capacity Expansion

    gurufocus.com

    2026-02-12 00:04:00

    Revenue: $2.4 billion in Q4, up 7% year over year on a normalized and constant currency basis.Monthly Recurring Revenue (MRR) Growth: 10% in Q4 and 8% for the

    https://images.financialmodelingprep.com/news/dont-overlook-aptargroup-atr-international-revenue-trends-while-assessing-20260210.jpg
    Don't Overlook AptarGroup (ATR) International Revenue Trends While Assessing the Stock

    zacks.com

    2026-02-10 10:16:03

    Explore how AptarGroup's (ATR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

    https://images.financialmodelingprep.com/news/nuance-investments-llc-has-1376-million-stock-holdings-in-20260209.png
    Nuance Investments LLC Has $13.76 Million Stock Holdings in AptarGroup, Inc. $ATR

    defenseworld.net

    2026-02-09 04:38:44

    Nuance Investments LLC lifted its holdings in shares of AptarGroup, Inc. (NYSE: ATR) by 41.3% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 102,960 shares of the industrial products company's stock after buying an additional 30,080 shares during the period. AptarGroup comprises about

    https://images.financialmodelingprep.com/news/aptargroup-q4-earnings-call-highlights-20260208.png
    AptarGroup Q4 Earnings Call Highlights

    defenseworld.net

    2026-02-08 04:14:45

    AptarGroup (NYSE: ATR) reported strong fourth-quarter revenue growth but saw profitability pressured by product mix and higher-than-anticipated costs, as executives highlighted both momentum across core businesses and near-term headwinds tied to emergency medicine demand. Fourth-quarter results: revenue up, margins pressured For the quarter ended December 31, 2025, Aptar reported sales of $963 million, up 14% from

    https://images.financialmodelingprep.com/news/aptargroup-inc-atr-q4-2025-earnings-call-transcript-20260206.jpg
    AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript

    seekingalpha.com

    2026-02-06 15:44:22

    AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript

    https://images.financialmodelingprep.com/news/aptargroup-atr-reports-q4-earnings-what-key-metrics-have-20260205.jpg
    AptarGroup (ATR) Reports Q4 Earnings: What Key Metrics Have to Say

    zacks.com

    2026-02-05 20:00:35

    While the top- and bottom-line numbers for AptarGroup (ATR) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

    https://images.financialmodelingprep.com/news/aptargroup-atr-q4-earnings-and-revenues-surpass-estimates-20260205.jpg
    AptarGroup (ATR) Q4 Earnings and Revenues Surpass Estimates

    zacks.com

    2026-02-05 19:10:19

    AptarGroup (ATR) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.52 per share a year ago.

    https://images.financialmodelingprep.com/news/aptar-reports-fourth-quarter-and-annual-2025-results-20260205.jpg
    Aptar Reports Fourth Quarter and Annual 2025 Results

    businesswire.com

    2026-02-05 17:00:00

    CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2025 Results.

    https://images.financialmodelingprep.com/news/earnings-preview-aptargroup-atr-q4-earnings-expected-to-decline-20260129.jpg
    Earnings Preview: AptarGroup (ATR) Q4 Earnings Expected to Decline

    zacks.com

    2026-01-29 11:01:17

    AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    https://images.financialmodelingprep.com/news/aptar-declares-quarterly-dividend-and-announces-2026-annual-meeting-20260122.jpg
    Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details

    businesswire.com

    2026-01-22 17:00:00

    CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details.

    https://images.financialmodelingprep.com/news/campbell-co-investment-adviser-llc-makes-new-investment-in-20260122.png
    Campbell & CO Investment Adviser LLC Makes New Investment in AptarGroup, Inc. $ATR

    defenseworld.net

    2026-01-22 03:51:24

    Campbell and CO Investment Adviser LLC acquired a new stake in AptarGroup, Inc. (NYSE: ATR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,008 shares of the industrial products company's stock, valued at approximately $536,000. Other hedge

    https://images.financialmodelingprep.com/news/aptar-again-recognized-with-prestigious-a-score-on-the-20260121.jpg
    Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment

    businesswire.com

    2026-01-21 17:00:00

    CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment.

    https://images.financialmodelingprep.com/news/aptargroup-inc-nyseatr-given-average-recommendation-of-hold-by-20260116.png
    AptarGroup, Inc. (NYSE:ATR) Given Average Recommendation of “Hold” by Brokerages

    defenseworld.net

    2026-01-16 01:22:48

    AptarGroup, Inc. (NYSE: ATR - Get Free Report) has been assigned a consensus rating of "Hold" from the seven brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company.